Goldman Sachs and Evercore ISI analysts have raised price targets for GE HealthCare Technologies (GEHC), citing a projected market recovery and strong capital expenditure trends by 2026. The medical devices firm is highlighted as a top hedge fund pick.
Analyst Matthew O'Brien reaffirms an Overweight rating and $420 price target for Stryker, highlighting the potential of its new Mako RPS handheld orthopedic robot to capture cost-sensitive markets and compete with rivals like Zimmer Biomet.
SLB has won significant five-year contracts from Petroleum Development Oman for the giant Block-6 field. The deals mandate local wellhead manufacturing and deploy advanced recovery technologies, anchoring SLB's long-term service role and supporting Omani job creation.
Deere & Company is doubling down on American manufacturing with a new excavator plant and parts center, part of a broader $20 billion commitment. While the move strengthens its long-term industrial narrative, near-term challenges from leadership changes to cyclical market pressures remain in focus.
Facing ongoing labor disputes, Starbucks unveils a massive investment in new espresso machines, AI-assisted POS systems, and a store rating program aimed at streamlining operations and improving the partner experience.
U.S. stocks fell and precious metals plunged from record highs after President Trump nominated former Fed Governor Kevin Warsh to lead the central bank, sparking concerns over monetary policy direction and Fed independence.
The collapse of Big Rock Sports, a major behind-the-scenes distributor for hunting and fishing retailers, marks another casualty in the sporting goods sector's struggle against e-commerce dominance and shifting consumer habits.
Canadian National Railway announced the retirement of veteran investor relations executive Stacy Alderson, capping a 30-year career. Vice President of Engineering Jamie Lockwood will assume the expanded role of VP, Investor Relations and Special Projects, as the railway giant navigates a strategic transition.
An unexpected jump in the Producer Price Index for December underscores the stubborn nature of inflation, with rising wholesale costs threatening to ripple through the economy and sustain higher prices for households.
Insulet (PODD) shares have faced significant pressure in recent months, diverging from the company's underlying business performance. This analysis delves into whether the current price weakness presents a buying opportunity for the Omnipod maker or reflects deeper market concerns about its premium valuation and growth sustainability.
Despite posting a Q4 net loss, Covenant Logistics signals a shift in market dynamics, with executives pointing to rising spot rates, secured contract increases, and a disciplined fleet strategy as precursors to a stronger performance by late 2026.
MKS Instruments' recent €1 billion debt offering to refinance its balance sheet arrives as its stock rides a powerful rally, forcing investors to weigh strong operational momentum against a valuation that appears stretched.
Shares of diabetes care innovator Insulet have tumbled nearly 10% year-to-date, sparking a fierce debate among investors. While a key valuation model suggests the stock is deeply undervalued, its sky-high P/E ratio tells a conflicting story. We examine the numbers and what they mean for the future of the Omnipod maker.
New satellite imagery shows Iran constructing roofs over bomb-damaged buildings at its Isfahan and Natanz nuclear facilities, a move analysts say is likely aimed at shielding recovery efforts from surveillance as international pressure mounts over Tehran's internal crackdown and nuclear ambitions.
Despite posting quarterly results that beat analyst expectations, KLA Corporation's stock plunged Friday as investors focused on management warnings about component shortages, tariff impacts, and operational constraints.
The FDA clearance of Spectrum Dynamics' Veritas.AI platform marks a significant step forward for nuclear imaging, promising to cut scan times in half and enhance image clarity for critical applications like cancer theranostics.
Stockholders of CSG Systems International have overwhelmingly approved a slate of key proposals, including governance changes and merger-related actions, during a recent virtual Extraordinary General Meeting. The approvals pave the way for the company's next phase of strategic growth.
John B. Sanfilippo & Son posts record revenue and a 32% jump in EPS for fiscal Q2 2026, even as higher nut costs and shifting consumer habits pressure sales volumes. The snack nut processor eyes future growth through operational efficiency and new bar production capacity.
Despite a challenging freight market, ArcBest reports resilient fourth-quarter performance, highlighting strategic cost controls, a turnaround in its asset-light segment, and significant investments in AI and automation to drive future efficiency.
Fermi Inc. is confronting multiple class action lawsuits alleging it misled investors about tenant demand and funding risks for its flagship AI data center project, Project Matador. The legal challenges emerge as the company navigates a high-stakes, capital-intensive build-out in a competitive sector.
